Literature DB >> 31392445

Incidence, clinical characteristics, and outcomes of Streptococcus dysgalactiae subspecies equisimilis bacteremia in a tertiary hospital: comparison with S. agalactiae bacteremia.

Joung Ha Park1, Jiwon Jung1, Min Jae Kim1, Heungsup Sung2, Mi-Na Kim2, Yong Pil Chong1, Sung-Han Kim1, Sang-Oh Lee1, Yang Soo Kim1, Jun Hee Woo1, Sang-Ho Choi3.   

Abstract

The clinical characteristics and outcomes of Streptococcus dysgalactiae subspecies equisimilis (SDSE) bacteremia cases have not been adequately evaluated. We retrospectively enrolled consecutive adult patients with SDSE or S. agalactiae (group B streptococci, GBS) bacteremia at a tertiary care hospital (Republic of Korea) from August 2012 to December 2016. We compared the incidence, seasonality, clinical characteristics, and outcomes of 52 SDSE bacteremia cases with 151 GBS bacteremia cases. The incidence of SDSE and GBS bacteremia in these patients was 1.28/100,000 and 4.22/100,000 person-days, respectively. Most SDSE bacteremia cases were of community-onset infection (SDSE 94.2% vs GBS 83.4%; p = 0.052). Lancefield group G was the most common bacteria type among SDSE isolates (43/47; 91.5%). Patients with SDSE bacteremia were older (median, 68.0 years vs 61.0 years; p = 0.03). In both groups, solid tumor was the most common underlying disease, and more than half of the patients were immunocompromised (51.9% vs 54.3%; p = 0.77). Chronic kidney disease was more common in the SDSE group (19.2% vs 5.3%; p < 0.01). Cellulitis was the most common clinical syndrome of SDSE bacteremia and was more common in the SDSE group (59.6% vs 29.1%; p < 0.01). SDSE bacteremia cases occurred more frequently in the warm season compared with GBS bacteremia cases (65.4% vs 37.1%; p < 0.01); in-hospital mortalities were not significantly different between the groups (3.8% vs 10.6%; p = 0.17). In conclusion, SDSE bacteremia is commonly associated with cellulitis, especially in older and immunocompromised patients during the warm season.

Entities:  

Keywords:  Bacteremia; Cellulitis; Streptococcus agalactiae; Streptococcus dysgalactiae

Mesh:

Substances:

Year:  2019        PMID: 31392445     DOI: 10.1007/s10096-019-03667-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  16 in total

1.  Delineation of Streptococcus dysgalactiae, its subspecies, and its clinical and phylogenetic relationship to Streptococcus pyogenes.

Authors:  Anders Jensen; Mogens Kilian
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Invasive group A, C and G streptococcal disease in western Norway: virulence gene profiles, clinical features and outcomes.

Authors:  B R Kittang; T Bruun; N Langeland; H Mylvaganam; M Glambek; S Skrede
Journal:  Clin Microbiol Infect       Date:  2011-03       Impact factor: 8.067

Review 3.  Streptococcus dysgalactiae subsp. equisimilis bacteremia: an emerging infection.

Authors:  S Rantala
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-03-29       Impact factor: 3.267

4.  Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.

Authors:  N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton
Journal:  Ann Intern Med       Date:  2002-11-19       Impact factor: 25.391

5.  Warmer Weather as a Risk Factor for Cellulitis: A Population-based Investigation.

Authors:  Ryan A Peterson; Linnea A Polgreen; Daniel K Sewell; Philip M Polgreen
Journal:  Clin Infect Dis       Date:  2017-10-01       Impact factor: 9.079

6.  Clearance of carbapenemase-producing Enterobacteriaceae (CPE) carriage: a comparative study of NDM-1 and KPC CPE.

Authors:  Y J Lim; H Y Park; J Y Lee; S H Kwak; M N Kim; H Sung; S-H Kim; S H Choi
Journal:  Clin Microbiol Infect       Date:  2018-06-02       Impact factor: 8.067

7.  Correlation of virulence genes to clinical manifestations and outcome in patients with Streptococcus dysgalactiae subspecies equisimilis bacteremia.

Authors:  Chia-Ta Tsai; Chih-Yu Chi; Cheng-Mao Ho; Po-Chang Lin; Chia-Hui Chou; Jen-Hsien Wang; Jui-Hsing Wang; Hsiao-Chuan Lin; Ni Tien; Kuo-Hsi Lin; Mao-Wang Ho; Jang-Jih Lu
Journal:  J Microbiol Immunol Infect       Date:  2013-11-07       Impact factor: 4.399

Review 8.  What happened to the streptococci: overview of taxonomic and nomenclature changes.

Authors:  Richard Facklam
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

Review 9.  Severe invasive streptococcal infection by Streptococcus pyogenes and Streptococcus dysgalactiae subsp. equisimilis.

Authors:  Shinya Watanabe; Norihiko Takemoto; Kohei Ogura; Tohru Miyoshi-Akiyama
Journal:  Microbiol Immunol       Date:  2016-01       Impact factor: 1.955

10.  Bacteremia caused by group G Streptococci, taiwan.

Authors:  Chun-Hsing Liao; Liang-Chun Liu; Yu-Tsung Huang; Lee-Jeng Teng; Po-Ren Hsueh
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.